Ajinomoto Videos
-
Breaking Bad Manufacturing Habits: Attaining Sustainable API Production
3/6/2024
Sustainability is a growing issue in the pharmaceutical industry. Review strategies for reducing your carbon footprint and learn how the right CDMO can help drive the sustainable manufacture of APIs.
-
Ajinomoto Bio-Pharma Services Capacity Update February 2024: Small Molecule
2/28/2024
Explore the recent expansions of Ajinomoto BPS. Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late-stage projects.
-
The Fundamental Outsourcing Question All Sponsors Face
10/24/2023
To end our Outsourced Pharma Live event on strategies for quality and regulatory outsourcing challenges, Chief Editor Louis Garguilo emphasizes the crucial question to ask when selecting a CDMO.
-
How To Connect Quality And Regulatory “At The Hip”
10/24/2023
Our Outsourced Pharma Live panel of experts introduce challenges and strategies to ensure your internal – and external partners’ – quality and regulatory professionals work together.
-
File First In Europe, Then The U.S.?
10/24/2023
Karla Knower, Global Head of Regulatory Affairs, Paradigm Biopharmaceuticals, answers a challenging question from an attendee at a recent Outsourced Pharma Live.
-
The Nature Of Quality Management Needs To Change
10/24/2023
In these 3 minutes, Bikash Chatterjee, an Outsourced Pharma Board Member, discusses how the current drug development and manufacturing landscape necessitates different approaches for quality teams.
-
The Wrong Way For Your CDMO To Upgrade Facilities
10/24/2023
Christine Feaster, who has worked for top 50 pharma and start-up organizations, relates a case study as a warning to sponsors when CDMOs look to upgrade facilities and add capabilities.
-
Today’s Quality And Regulatory Workforce Challenges
10/24/2023
Erin O'Brien (Biogen), Christine Feaster (QxP), and Bikash Chatterjee (Pharmactech Associates) discuss new workforce realities and tactics at sponsors and CDMOs that followed the "great resignation."
-
Quality Agreements, Inspections, And PQS
10/24/2023
Karla Knower of Paradigm Biopharmaceuticals informs Outsourced Pharma Live attendees about quality agreements, inspections, and implementing a Pharmaceutical Quality System (PQS).
-
Accelerated Approval Pressures Starting Materials
10/24/2023
Our panel of outsourcing experts discuss the need for speed in today’s development of drugs and therapies, and how that impacts the quest for and maintenance of quality starting materials.